The viral E8^E2C repressor limits productive replication of human papillomavirus 16

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 937-947

  Straub, Elke ^a   Dreer, Marcel ^a   Fertey, Jasmin ^a   Iftner, Thomas ^a   Stubenrauch, Frank ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

E8 E2C FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; E8 E2C GENE; GENE DOSAGE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MITOCHONDRIAL GENOME; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; VIROGENESIS; VIRUS CULTURE; VIRUS GENE; VIRUS GENOME; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

AMINO ACID MOTIFS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, FUSION; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; VIRUS REPLICATION;

EID: 84891697733     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02296-13     Document Type: Article

References (49)

1. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6:204. http://dx.doi.org/10.1016/S1470-2045(05)70086-3.
2. Parkin DM, Bray F. 2006. Chapter 2. The burden of HPV-related cancers. Vaccine 24(Suppl 3):S3/11-S3/25. http://dx.doi.org/10.1016/j.vaccine.2006.05.111.
3. Schiffman M, Clifford G, Buonaguro FM. 2009. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect. Agents Cancer 4:8. http://dx.doi.org/10.1186/1750-9378-4-8.
4. Schwartz S. 2013. Papillomavirus transcripts and posttranscriptional regulation. Virology 445:187-196. http://dx.doi.org/10.1016/j.virol.2013.04.034.
5. Stubenrauch F, Laimins LA. 1999. Human papillomavirus life cycle: active and latent phases. Semin. Cancer Biol. 9:379-386. http://dx.doi.org/10.1006/scbi.1999.0141.
6. Stenlund A. 2003. Initiation of DNA replication: lessons from viral initiator proteins. Nat. Rev. Mol. Cell Biol. 4:777-785. http://dx.doi.org/10.1038/nrm1226.
7. Breiding DE, Sverdrup F, Grossel MJ, Moscufo N, Boonchai W, Androphy EJ. 1997. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol. Cell. Biol. 17:7208-7219.
8. Donaldson MM, Mackintosh LJ, Bodily JM, Dornan ES, Laimins LA, Morgan IM. 2012. An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J. Virol. 86:12806-12815. http://dx.doi.org/10.1128/JVI.01002-12.
9. Wang X, Helfer CM, Pancholi N, Bradner JE, You J. 2013. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J. Virol. 87:3871-3884. http://dx.doi.org/10.1128/JVI.03068-12.
10. McBride AA, Sakakibara N, Stepp WH, Jang MK. 2012. Hitchhiking on host chromatin: how papillomaviruses persist. Biochim. Biophys. Acta 1819:820-825. http://dx.doi.org/10.1016/j.bbagrm.2012.01.011.
11. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550-560. http://dx.doi.org/10.1038/nrc2886.
12. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23:181-194. http://dx.doi.org/10.1101/gad.1735109.
13. Bohm S, Wilczynski SP, Pfister H, Iftner T. 1993. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int. J. Cancer 55:791-798. http://dx.doi.org/10.1002/ijc.2910550517.
14. Grassmann K, Rapp B, Maschek H, Petry KU, Iftner T. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:2339-2349.
15. Hummel M, Hudson JB, Laimins LA. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
16. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM. 2011. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J. Virol. 85:8080-8092. http://dx.doi.org/10.1128/JVI.00670-11.
17. Doorbar J, Foo C, Coleman N, Medcalf L, Hartley O, Prospero T, Napthine S, Sterling J, Winter G, Griffin H. 1997. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238:40-52. http://dx.doi.org/10.1006/viro.1997.8768.
18. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF. 2000. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J. Virol. 74:6622-6631. http://dx.doi.org/10.1128/JVI.74.14.6622-6631.2000.
19. McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. 2005. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 338:61-68. http://dx.doi.org/10.1016/j.virol.2005.04.036.
20. Kho EY, Wang HK, Banerjee NS, Broker TR, Chow LT. 2013. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc. Natl. Acad. Sci. U. S. A. 110:7542-7549. http://dx.doi.org/10.1073/pnas.1304855110.
21. Fehrmann F, Klumpp DJ, Laimins LA. 2003. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77:2819-2831. http://dx.doi.org/10.1128/JVI.77.5.2819-2831.2003.
22. Genther SM, Sterling S, Duensing S, Munger K, Sattler C, Lambert PF. 2003. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77:2832-2842. http://dx.doi.org/10.1128/JVI.77.5.2832-2842.2003.
23. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF. 2005. Human papillomavirus type 16 E1^E4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79:13150-13165. http://dx.doi.org/10.1128/JVI.79.20.13150-13165.2005.
24. Wilson R, Fehrmann F, Laimins LA. 2005. Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79:6732-6740. http://dx.doi.org/10.1128/JVI.79.11.6732-6740.2005.
25. Choe J, Vaillancourt P, Stenlund A, Botchan M. 1989. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 63:1743-1755.
26. Doorbar J, Parton A, Hartley K, Banks L, Crook T, Stanley M, Crawford L. 1990. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 178:254-262. http://dx.doi.org/10.1016/0042-6822(90)90401-C.
27. Fertey J, Hurst J, Straub E, Schenker A, Iftner T, Stubenrauch F. 2011. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein. J. Virol. 85:2918-2926. http://dx.doi.org/10.1128/JVI.01647-10.
28. Jeckel S, Loetzsch E, Huber E, Stubenrauch F, Iftner T. 2003. Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus. J. Virol. 77:8736-8744. http://dx.doi.org/10.1128/JVI.77.16.8736-8744.2003.
29. Kurg R, Uusen P, Vosa L, Ustav M. 2010. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 408:159-166. http://dx.doi.org/10.1016/j.virol.2010.09.010.
30. Lace MJ, Anson JR, Thomas GS, Turek LP, Haugen TH. 2008. The E8-E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J. Virol. 82:10841-10853. http://dx.doi.org/10.1128/JVI.01481-08.
31. Palermo-Dilts DA, Broker TR, Chow LT. 1990. Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts. J. Virol. 64:3144-3149.
32. Rotenberg MO, Chow LT, Broker TR. 1989. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology 172:489-497. http://dx.doi.org/10.1016/0042-6822(89)90191-8.
33. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Raaphorst PM, Meijer CJ, Walboomers JM. 1992. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites. J. Virol. 66:3172-3178.
34. Stubenrauch F, Hummel M, Iftner T, Laimins LA. 2000. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 74:1178-1186. http://dx.doi.org/10.1128/JVI.74.3.1178-1186.2000.
35. Zobel T, Iftner T, Stubenrauch F. 2003. The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol. Cell. Biol. 23:8352-8362. http://dx.doi.org/10.1128/MCB.23.22.8352-8362.2003.
36. Stubenrauch F, Straub E, Fertey J, Iftner T. 2007. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins. Int. J. Cancer 121:2284-2292. http://dx.doi.org/10.1002/ijc.22907.
37. Stubenrauch F, Zobel T, Iftner T. 2001. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31. J. Virol. 75:4139-4149. http://dx.doi.org/10.1128/JVI.75.9.4139-4149.2001.
38. Powell ML, Smith JA, Sowa ME, Harper JW, Iftner T, Stubenrauch F, Howley PM. 2010. NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J. Virol. 84:4451-4460. http://dx.doi.org/10.1128/JVI.02390-09.
39. Ammermann I, Bruckner M, Matthes F, Iftner T, Stubenrauch F. 2008. Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules. J. Virol. 82:5127-5136. http://dx.doi.org/10.1128/JVI.02647-07.
40. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, Lowy DR, Schiller JT. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
41. Ahmad SS, Glatzle J, Bajaeifer K, Buhler S, Lehmann T, Konigsrainer I, Vollmer JP, Sipos B, Ahmad SS, Northoff H, Konigsrainer A, Zieker D. 2013. Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer. Int. J. Oncol. 43:586-590. http://dx.doi.org/10.3892/ijo.2013.1971.
42. Schenker A, Straub E, Iftner T, Stubenrauch F. 2013. Cell-type-dependent activities of regulatory regions and E2 proteins derived from carcinogenic and non-carcinogenic human alphapapillomaviruses. J. Gen. Virol. 94:1343-1350. http://dx.doi.org/10.1099/vir.0.049072-0.
43. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. 2000. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:1436-1447. http://dx.doi.org/10.1128/MCB.20.4.1436-1447.2000.
44. Rozen SS, Helen J. 2000. Primer3 on the WWW for general users and for biologist programmers, p 365-386. In Misener S, Krawetz SA (ed), Bioinformatics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ.
45. Fradet-Turcotte A, Morin G, Lehoux M, Bullock PA, Archambault J. 2010. Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology 399:65-76. http://dx.doi.org/10.1016/j.virol.2009.12.026.
46. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349. http://dx.doi.org/10.1101/gad.9.19.2335.
47. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, El-Sherif A, Morris L, Seth R, Hibma M, Jenkins D, Lambert P, Coleman N, Doorbar J. 2003. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 77:10186-10201. http://dx.doi.org/10.1128/JVI.77.19.10186-10201.2003.
48. Peh WL, Middleton K, Christensen N, Nicholls P, Egawa K, Sotlar K, Brandsma J, Percival A, Lewis J, Liu WJ, Doorbar J. 2002. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 76:10401-10416. http://dx.doi.org/10.1128/JVI.76.20.10401-10416.2002.
49. Spink KM, Laimins LA. 2005. Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J. Virol. 79:4918-4926. http://dx.doi.org/10.1128/JVI.79.8.4918-4926.2005.